Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory MechanismAlexander Duscha, Aiden Haghikia, Sivan Amidror et al.|Cell|2020Cited by 627
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosisCarsten Lukas, Hugo Vrenken|Journal of Neurology Neurosurgery & Psychiatry|2014Cited by 139
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatmentSimon Faissner, Gisa Ellrichmann, Robert Hoepner et al.|Therapeutic Advances in Neurological Disorders|2015Cited by 53
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre studyMaria A. Rocca, Massimo Filippi, Paola Valsasina et al.|Journal of Neurology Neurosurgery & Psychiatry|2022Cited by 34
Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasisRobert Hoepner, Andrew Chan, Simon Faissner et al.|Neurology Neuroimmunology & Neuroinflammation|2015Cited by 26